Blog

Rajat Thawani: Talking about biomarkers in lung cancer

Photo taken from Rajat Thawani/X

Sep 12, 2024, 15:39

Rajat Thawani: Talking about biomarkers in lung cancer

Rajat Thawani, Assistant Professor, University of Chicago, shared a post by Physician’s Weekly on X, adding:

“Talking about biomarkers in lung cancer. Every patients deserves testing to determine the right treatment.”

Quoting Physician’s Weekly:

“In today’s PeerPOV podcast, Rajat Thawani of University of Chicago Hematology/Oncology discusses the role of specialized biomarker testing teams & why biomarker testing is crucial in guiding treatment decisions for patients with ROS1 mutations in NSCLC. Tune in here.”

Source: Rajat Thawani/X and Physician’s Weekly/X

cancer cancer awareness fight against cancer Lung cancer NSCLC OncoDaily Oncology PeerPOV Physician's Weekly Rajat Thawani University of Chicago Hematology/Oncology

Dr. Manette Le Grange joins OncoDaily Editorial Board

FDA Grants Priority Review to Merck’s Application for KEYTRUDA® (pembrolizumab) Plus Standard of Care as Perioperative Treatment for Resectable Locally Advanced Head and Neck Squamous Cell Carcinoma

New Paper Alert Real-Life Impact of Enfortumab Vedotin or Chemotherapy in the Sequential Treatment of Advanced Urothelial Carcinoma: The ARON-2 Retrospective Experience

Highlights from TTLC2025

KIMMTRAK (Tebentafusp) uses in Cancer: Dosages, Indications, Expectations and more